title: Medications for the treatment of Alzheimer's disease.
abstract: At the time this article was written, there were only three medications approved by the Federal Drug Administration for the treatment of Alzheimer's Disease. Currently there are four approved medications. The newest drug, galantamine, is not reviewed in this article.
authors.affiliation: Donald W. Reynolds Department of Geriatric Medicine, 921 NE 13th Street, VA Medical Center, #11G-Geriatrics, Oklahoma City, OK 73104-5028, USA.
authors.forename: V T
authors.initials: VT
authors.lastname: Lampley-Dallas
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D000975:Antioxidants / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000077265:Donepezil; D015914:Estrogen Replacement Therapy; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D048448:Phenylcarbamates; D010880:Piperidines / Q000627:therapeutic use; D000068836:Rivastigmine; D013619:Tacrine / Q000627:therapeutic use
chemical_list: D000975:Antioxidants; D002219:Carbamates; D002800:Cholinesterase Inhibitors; D007189:Indans; D048448:Phenylcarbamates; D010880:Piperidines; D013619:Tacrine; D000077265:Donepezil; D000068836:Rivastigmine